SCHEMBL16474255

SCHEMBL16474255

CC(c1ccc(OCC(O)COc2ccc(C(C)c3ccc(OCC4CO4)cc3)cc2)cc1)c1ccc(OCC2CO2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
TSHR P16473 4/20 0.50
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 4/20 0.50
TP53 P04637 3/20 0.50
MAPT P10636 3/20 0.50
HPGD P15428 3/20 0.50
HIF1A Q16665 2/20 0.50
CYP1A2 P05177 1/20 0.50
PPARG P37231 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
PKM P14618 2/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 1/20 0.47
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP3A4 P08684 1/20 0.44
POLB P06746 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GLA P06280 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18016698 0.91 KMT2A (0.67) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL13514845 0.91 KMT2A (0.45) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL234681 0.89 ALDH1A1 (0.60) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL17051339 0.88 TDP1 (0.51) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL6757523 0.85 KMT2A (0.45) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL16199118 0.85 ALDH1A1 (0.53) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL10259735 0.85 TDP1 (0.54) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL15344079 0.85 TDP1 (0.54) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL3148179 0.84 TDP1 (0.67) KMT2ATSHRALDH1A1MEN1TP53
SCHEMBL17898603 0.83 TDP1 (0.46) KMT2ATSHRALDH1A1MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359324-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-06-07 US disclosed
US-20150197501-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-07-16 US disclosed
US-9051293-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-06-09 US disclosed
US-20140107350-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197501-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS KMT2A 867/4885TSHR 1233/4885ALDH1A1 405/4885
US-20140107350-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS KMT2A 867/4885TSHR 1233/4885ALDH1A1 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.